Octave Specialty Group Reports Third Quarter 2026 Results
-
Insurance Distribution Segment
- Total revenue grew 35% to $58 million
- Organic revenue growth equaled 23%
- Net loss to shareholders totaled $(4.2) million, compared to $(5.4) million in 3Q25
- Adjusted EBITDA to shareholders totaled $8.3 million, compared to $6.0 million in 3Q25
-
Specialty P&C Insurance Segment ("Everspan")
- Gross and net premiums written totaled $99 million and $26 million, up 2% and 44%, respectively
- Net income equaled $1.3 million, compared to a net loss of $(0.1) million in 3Q25
- Adjusted EBITDA to shareholders totaled $2.2 million, compared to less than $0.1 million in 3Q25
NEW YORK--(BUSINESS WIRE)--Octave Specialty Group, Inc. (NYSE: OSG) ("Octave" or "OSG"), a global specialty insurance firm, today reported its results for the third quarter of 2026.
Claude LeBlanc, President and Chief Executive Officer of Octave, said "Octave delivered a solid third quarter, with continued growth in our Insurance Distribution business and further progress at Everspan, despite a P&C market that has become more competitive as the year has progressed. While we expect market softening to continue into 2027, we believe that our operating model was built to perform through market cycles, and Octave is well positioned to deliver sustained, profitable growth toward our long-term goals."
LeBlanc continued, "In the third quarter, we grew our Insurance Distribution revenue 35%, including organic revenue growth of 23%. This strong organic growth, well ahead of the broader industry, is consistent with our seasonally adjusted third quarter plan and reflects the strength of our purposely diversified portfolio strategy and the strong embedded value of our scaling MGA incubator. Insurance Distribution Adjusted EBITDA to shareholders was $8.3 million, compared to $6.0 million in the prior-year period.
"Everspan's results continue to reflect the repositioning of its growing programs business. During the third quarter, the combined ratio improved meaningfully from the prior-year period. Specialty P&C Insurance Adjusted EBITDA to shareholders was $2.2 million, compared to less than $0.1 million in the prior-year period. Subsequent to quarter end, Everspan entered into an agreement to sell its redundant admitted shell company, Providence Washington Insurance Company, which is expected to help simplify its operating structure and further strengthen its capital base."
Octave's Third Quarter 2026 Summary Results | ||||||||||||||||||||||
|
| Three Months Ended September 30, |
| Nine Months Ended September 30, | ||||||||||||||||||
(in thousands, except per share data)(1) |
|
| 2026 |
|
|
| 2025 |
|
| % Change |
|
| 2026 |
|
|
| 2025 |
|
| % Change | ||
Total revenues |
| $ | 85,343 |
|
| $ | 66,606 |
|
| 28 | % |
| $ | 272,508 |
|
| $ | 184,319 |
|
| 48 | % |
Total expenses |
| $ | 98,722 |
|
| $ | 98,685 |
|
| — | % |
| $ | 300,902 |
|
| $ | 254,479 |
|
| 18 | % |
Pretax income (loss) from continuing operations |
| $ | (13,379 | ) |
| $ | (32,079 | ) |
| NM |
|
| $ | (28,394 | ) |
| $ | (70,160 | ) |
| NM |
|
Provision (benefit) for income taxes from continuing operations |
| $ | (521 | ) |
| $ | (1,241 | ) |
| NM |
|
| $ | (517 | ) |
| $ | (4,030 | ) |
| NM |
|
Net income (loss) from continuing operations |
| $ | (12,858 | ) |
| $ | (30,838 | ) |
| NM |
|
| $ | (27,877 | ) |
| $ | (66,130 | ) |
| NM |
|
Net income (loss) from continuing operations attributable to shareholders, net of tax |
| $ | (13,797 | ) |
| $ | (31,730 | ) |
| NM |
|
| $ | (35,077 | ) |
| $ | (68,422 | ) |
| NM |
|
Net income (loss) from discontinued operations |
| $ | — |
|
| $ | (80,890 | ) |
| NM |
|
| $ | — |
|
| $ | (163,288 | ) |
| NM |
|
Net income (loss) attributable to shareholders |
| $ | (13,797 | ) |
| $ | (112,620 | ) |
| NM |
|
| $ | (35,077 | ) |
| $ | (231,710 | ) |
| NM |
|
Net income (loss) from continuing operations attributable to shareholders per diluted share (3) |
| $ | (0.31 | ) |
| $ | (0.65 | ) |
| (52 | )% |
| $ | (0.78 | ) |
| $ | (1.64 | ) |
| (52 | )% |
Net income (loss) attributable to shareholders per diluted share (3) |
| $ | (0.31 | ) |
| $ | (2.33 | ) |
| (87 | )% |
| $ | (0.78 | ) |
| $ | (5.05 | ) |
| (85 | )% |
Non-GAAP(2) |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
EBITDA to shareholders |
| $ | (1,807 | ) |
| $ | (20,075 | ) |
| NM |
|
| $ | 66 |
|
| $ | (35,420 | ) |
| NM |
|
Adjusted EBITDA to shareholders |
| $ | 3,333 |
|
| $ | (2,856 | ) |
| NM |
|
| $ | 27,087 |
|
| $ | (8,734 | ) |
| NM |
|
Adjusted net income (loss) attributable to shareholders |
| $ | (1,265 | ) |
| $ | (9,957 | ) |
| NM |
|
| $ | 13,537 |
|
| $ | (26,546 | ) |
| NM |
|
Per Share |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Adjusted net income (loss) to shareholders per diluted share(2) |
| $ | (0.03 | ) |
| $ | (0.21 | ) |
| (86 | )% |
| $ | 0.30 |
|
| $ | (0.55 | ) |
| NM |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Weighted-average diluted shares outstanding |
|
| 45,419 |
|
|
| 48,106 |
|
| (6 | )% |
|
| 45,371 |
|
|
| 47,862 |
|
| (5 | )% |
(1) | Some financial data in this press release may not add up due to rounding | |
(2) | See Non-GAAP Financial Data section of this press release for further information | |
(3) | Per diluted share includes the impact of adjusting redeemable noncontrolling interests to current redemption value |
Third Quarter 2026 Summary(4)
Total revenue for the third quarter of 2026 was $85.3 million, an increase of 28% compared to $66.6 million in the prior-year period. The increase was driven by 35% revenue growth in the Insurance Distribution segment, reflecting organic revenue growth of 23% and the acquisition of ArmadaCare, as well as 52% earned premium growth at Everspan.
Octave's net (loss) from continuing operations attributable to shareholders for the third quarter of 2026 improved to $(13.8) million, compared to $(31.7) million in the prior-year period. The improvement was attributable to (i) the Insurance Distribution segment, which reported a net (loss) to shareholders of $(4.2) million, compared to $(5.4) million in the prior-year period, (ii) the Specialty P&C Insurance segment, where Everspan reported net income of $1.3 million, compared to a net (loss) of $(0.1) million in the prior-year period, and (iii) a reduction in the Corporate net (loss) to $(10.8) million from $(26.3) million in the prior-year period.
Adjusted EBITDA to shareholders for the third quarter of 2026 improved to $3.3 million, compared to $(2.9) million in the prior-year period. The improvement was driven by a $2.3 million increase in Insurance Distribution Adjusted EBITDA to shareholders. In addition, the third quarter of 2026 Adjusted EBITDA to shareholders improved for Everspan and Corporate by $2.2 million and $1.8 million, respectively, from a year ago.
Adjusted net (loss) to shareholders for the third quarter of 2026 improved to $(1.3) million, compared to $(10.0) million in the prior-year period, reflecting lower interest expense, growth in the Insurance Distribution and Specialty P&C Insurance segments, and a smaller Corporate Adjusted net (loss).
(4) | For definitions of each non-GAAP measure referred to above, as well as reconciliation of such non-GAAP measures to their most directly comparable GAAP measures, see "Non-GAAP Financial Measures" below. |
Earnings Call and Webcast
On November 10, 2026, at 8:30am ET, Claude LeBlanc, President and Chief Executive Officer, and David Trick, Executive Vice President and Chief Financial Officer, will discuss Octave's third quarter 2026 results during a conference call. A live audio webcast of the call will be available through the Investor Relations section of Octave’s website, https://octavegroup.com/investor-relations/events-and-presentations. Participants may also listen via telephone by dialing (877) 407-9716 or (201) 493-6779.
The webcast will be archived on Octave's website. A replay of the call will be available through November 24, 2026, and can be accessed by dialing (Domestic) (844) 512-2921 or (International) (412) 317-6671; and using ID# 13762730.
Additional information is included in an operating supplement and presentations on Octave's website, www.octavegroup.com.
Results of Operations by Segment | ||||||||||||||||||||||
Insurance Distribution Segment | ||||||||||||||||||||||
|
| Three Months Ended September 30, |
| Nine Months Ended September 30, | ||||||||||||||||||
($ in thousands)(1) |
|
| 2026 |
|
|
| 2025 |
|
| % Change |
|
| 2026 |
|
|
| 2025 |
|
| % Change | ||
Premiums placed |
| $ | 293,362 |
|
| $ | 245,394 |
|
| 20 | % |
| $ | 1,034,562 |
|
| $ | 728,493 |
|
| 42 | % |
Total revenues |
| $ | 58,364 |
|
| $ | 43,222 |
|
| 35 | % |
| $ | 195,308 |
|
| $ | 117,261 |
|
| 67 | % |
Pretax income (loss) |
| $ | (3,640 | ) |
| $ | (5,747 | ) |
| NM |
|
| $ | 12,299 |
|
| $ | (18,159 | ) |
| NM |
|
Pretax income (loss) to shareholders(2) |
| $ | (4,721 | ) |
| $ | (6,639 | ) |
| NM |
|
| $ | 4,844 |
|
| $ | (20,451 | ) |
| NM |
|
Net income (loss) |
| $ | (3,115 | ) |
| $ | (4,506 | ) |
| NM |
|
| $ | 12,713 |
|
| $ | (14,237 | ) |
| NM |
|
Net income (loss) to shareholders(2) |
| $ | (4,196 | ) |
| $ | (5,398 | ) |
| NM |
|
| $ | 5,258 |
|
| $ | (16,529 | ) |
| NM |
|
EBITDA(4) |
| $ | 11,042 |
|
| $ | 9,855 |
|
| 12 | % |
| $ | 55,746 |
|
| $ | 26,640 |
|
| 109 | % |
EBITDA to shareholders(2)(4) |
| $ | 7,446 |
|
| $ | 5,928 |
|
| 26 | % |
| $ | 39,583 |
|
| $ | 15,508 |
|
| 155 | % |
Adjusted EBITDA(4) |
| $ | 12,255 |
|
| $ | 9,955 |
|
| 23 | % |
| $ | 60,579 |
|
| $ | 26,647 |
|
| 127 | % |
Adjusted EBITDA to shareholders(2)(4) |
| $ | 8,313 |
|
| $ | 5,988 |
|
| 39 | % |
| $ | 43,445 |
|
| $ | 15,599 |
|
| 179 | % |
Adjusted net income (loss)(4) |
| $ | 7,397 |
|
| $ | 2,799 |
|
| 164 | % |
| $ | 45,565 |
|
| $ | 9,147 |
|
| 398 | % |
Adjusted net income (loss) to shareholders(2)(4) |
| $ | 4,026 |
|
| $ | (784 | ) |
| NM |
|
| $ | 30,676 |
|
| $ | (1,248 | ) |
| NM |
|
Pretax income margin to shareholders(3) |
|
| (8.1 | )% |
|
| (15.4 | )% |
| 730 bps |
|
| 2.5 | % |
|
| (17.4 | )% |
| 1990 bps | ||
Adjusted EBITDA margin to shareholders(4),(5) |
|
| 14.2 | % |
|
| 13.9 | % |
| 30 bps |
|
| 22.2 | % |
|
| 13.3 | % |
| 890 bps | ||
Organic Growth(4) |
|
| 22.6 | % |
|
| 40.0 | % |
|
|
|
| 35.5 | % |
|
| 26.1 | % |
|
| ||
(1) | Reflects segment results prior to intersegment activities eliminated in consolidation. | |
(2) | After the impact of noncontrolling interests | |
(3) | Represents Pretax income (loss) to shareholders divided by total revenues | |
(4) | See Non-GAAP Financial Data section of this press release for further information | |
(5) | Represents Adjusted EBITDA to shareholders divided by total revenues |
Specialty Property & Casualty Insurance Segment
|
| Three Months Ended September 30, |
| Nine Months Ended September 30, | ||||||||||||||||||
($ in thousands)(1) |
|
| 2026 |
|
|
| 2025 |
|
| % Change |
|
| 2026 |
|
|
| 2025 |
|
| % Change | ||
Gross premium written |
| $ | 98,842 |
|
| $ | 97,185 |
|
| 2 | % |
| $ | 297,260 |
|
| $ | 280,347 |
|
| 6 | % |
Net premiums written |
| $ | 25,633 |
|
| $ | 17,777 |
|
| 44 | % |
| $ | 81,224 |
|
| $ | 50,988 |
|
| 59 | % |
Net premiums earned |
| $ | 25,816 |
|
| $ | 17,027 |
|
| 52 | % |
| $ | 67,566 |
|
| $ | 48,908 |
|
| 38 | % |
Total revenue |
| $ | 30,901 |
|
| $ | 22,774 |
|
| 36 | % |
| $ | 82,603 |
|
| $ | 65,335 |
|
| 26 | % |
Net income (loss) |
| $ | 1,271 |
|
| $ | (53 | ) |
| NM |
|
| $ | (5,300 | ) |
| $ | 1,799 |
|
| NM |
|
Adjusted EBITDA to shareholders(2) |
| $ | 2,214 |
|
| $ | 49 |
|
| 4418 | % |
| $ | 5,589 |
|
| $ | 2,319 |
|
| 141 | % |
Loss Ratio |
|
| 57.1 | % |
|
| 84.5 | % |
| (2740) bps |
|
| 70.7 | % |
|
| 73.3 | % |
| (260) bps | ||
Expense Ratio |
|
| 43.5 | % |
|
| 28.4 | % |
| 1510 bps |
|
| 44.4 | % |
|
| 34.1 | % |
| 1030 bps | ||
Combined Ratio |
|
| 100.6 | % |
|
| 112.9 | % |
| (1230) bps |
|
| 115.1 | % |
|
| 107.4 | % |
| 770 bps | ||
(1) | Reflects segment results prior to intersegment activities eliminated in consolidation. | |
(2) | See Non-GAAP Financial Data section of this press release for further information |
OSG Corporate (holding company only)
OSG on a standalone basis, excluding its ownership interests in its Specialty P&C Insurance and Insurance Distribution subsidiaries, had net assets of $45 million as of September 30, 2026. Assets included cash and liquid securities of $24 million and other investments of $21 million.
Consolidated Octave Specialty Group, Inc. Stockholders' Equity and Noncontrolling Interests ("NCI") Impact to EPS
Stockholders’ equity attributable to common shareholders at September 30, 2026, was $684 million, or $15.19 per share, compared to $699 million, or $15.52 per share, as of June 30, 2026. The decline was primarily a result of the total comprehensive loss attributable to common shareholders of $(18) million, partially offset by an increase in additional paid-in capital related to share-based compensation of $4 million.
Calculation of Earnings (Loss) Per Share (EPS)
Diluted net income (loss) per share is computed by dividing net income (loss) attributable to shareholders, adjusted for the direct retained earnings impacts of changes to redeemable noncontrolling interests, by the basic weighted-average shares outstanding plus all potentially dilutive common shares outstanding during the period. The following table provides a reconciliation of net income (loss) attributable to shareholders to the numerator in the diluted earnings per share calculation, together with the resulting earnings per share amounts:
|
Three Months Ended
|
|
Nine Months Ended
| ||||||||||||
(in thousands, except per share data) |
| 2026 |
|
|
| 2025 |
|
|
| 2026 |
|
|
| 2025 |
|
Net income (loss) from continuing operations attributable to shareholders | $ | (13,797 | ) |
| $ | (31,730 | ) |
| $ | (35,077 | ) |
| $ | (68,422 | ) |
Adjustment for Redeemable NCI |
| (244 | ) |
|
| 445 |
|
| $ | (174 | ) |
| $ | (10,157 | ) |
Numerator of diluted EPS | $ | (14,041 | ) |
| $ | (31,285 | ) |
| $ | (35,251 | ) |
| $ | (78,579 | ) |
Per Share — Diluted | $ | (0.31 | ) |
| $ | (0.65 | ) |
| $ | (0.78 | ) |
| $ | (1.64 | ) |
|
|
|
|
|
|
|
| ||||||||
Net income (loss) attributable to shareholders | $ | (13,797 | ) |
| $ | (112,620 | ) |
| $ | (35,077 | ) |
| $ | (231,710 | ) |
Adjustment for Redeemable NCI |
| (244 | ) |
|
| 445 |
|
|
| (174 | ) |
|
| (10,157 | ) |
Numerator of diluted EPS | $ | (14,041 | ) |
| $ | (112,175 | ) |
| $ | (35,251 | ) |
| $ | (241,867 | ) |
Per Share — Diluted | $ | (0.31 | ) |
| $ | (2.33 | ) |
| $ | (0.78 | ) |
| $ | (5.05 | ) |
|
|
|
|
|
|
|
| ||||||||
WASO-Diluted |
| 45,419 |
|
|
| 48,106 |
|
|
| 45,371 |
|
|
| 47,862 |
|
OCTAVE SPECIALTY GROUP, INC. AND SUBSIDIARIES Consolidated Statements of Income (Loss) (Unaudited) | ||||||||||||||||
|
|
Three Months Ended
|
|
Nine Months Ended
| ||||||||||||
($ in thousands, except share data) |
|
| 2026 |
|
|
| 2025 |
|
|
| 2026 |
|
|
| 2025 |
|
Revenues: |
|
|
|
|
|
|
|
| ||||||||
Commissions |
| $ | 48,015 |
|
| $ | 36,059 |
|
| $ | 165,921 |
|
| $ | 103,152 |
|
Servicing and other fees |
|
| 6,980 |
|
|
| 4,855 |
|
|
| 22,255 |
|
|
| 14,291 |
|
Net premiums earned |
|
| 25,816 |
|
|
| 17,027 |
|
|
| 67,566 |
|
|
| 48,908 |
|
Program fees |
|
| 3,569 |
|
|
| 3,590 |
|
|
| 10,506 |
|
|
| 10,739 |
|
Investment income |
|
| 2,034 |
|
|
| 2,666 |
|
|
| 6,266 |
|
|
| 8,090 |
|
Other |
|
| (1,071 | ) |
|
| 2,408 |
|
|
| (6 | ) |
|
| (862 | ) |
Total revenues |
|
| 85,343 |
|
|
| 66,606 |
|
|
| 272,508 |
|
|
| 184,319 |
|
Expenses: |
|
|
|
|
|
|
|
| ||||||||
Commissions |
|
| 9,755 |
|
|
| 11,167 |
|
|
| 32,268 |
|
|
| 28,935 |
|
Losses and loss adjustment expenses |
|
| 14,731 |
|
|
| 14,386 |
|
|
| 47,756 |
|
|
| 35,860 |
|
Policy acquisition costs |
|
| 7,213 |
|
|
| 3,491 |
|
|
| 19,943 |
|
|
| 11,031 |
|
General and administrative |
|
| 51,997 |
|
|
| 53,710 |
|
|
| 156,567 |
|
|
| 132,781 |
|
Intangible amortization and depreciation |
|
| 12,314 |
|
|
| 9,746 |
|
|
| 36,792 |
|
|
| 28,663 |
|
Interest |
|
| 2,712 |
|
|
| 6,185 |
|
|
| 7,576 |
|
|
| 17,209 |
|
Total expenses |
|
| 98,722 |
|
|
| 98,685 |
|
|
| 300,902 |
|
|
| 254,479 |
|
Pretax income (loss) from continuing operations |
|
| (13,379 | ) |
|
| (32,079 | ) |
|
| (28,394 | ) |
|
| (70,160 | ) |
Provision (benefit) for income taxes from continuing operations |
|
| (521 | ) |
|
| (1,241 | ) |
|
| (517 | ) |
|
| (4,030 | ) |
Net income (loss) from continuing operations |
|
| (12,858 | ) |
|
| (30,838 | ) |
|
| (27,877 | ) |
|
| (66,130 | ) |
Net income (loss) from discontinued operations |
|
| — |
|
|
| (80,890 | ) |
|
| — |
|
|
| (163,288 | ) |
Net income (loss) |
|
| (12,858 | ) |
|
| (111,728 | ) |
|
| (27,877 | ) |
|
| (229,418 | ) |
Net (gain) loss attributable to noncontrolling interest |
|
| (939 | ) |
|
| (892 | ) |
|
| (7,200 | ) |
|
| (2,292 | ) |
Net income (loss) attributable to shareholders |
| $ | (13,797 | ) |
| $ | (112,620 | ) |
| $ | (35,077 | ) |
| $ | (231,710 | ) |
|
|
|
|
|
|
|
|
| ||||||||
Net income (loss) from continuing operations attributable to shareholders |
| $ | (13,797 | ) |
| $ | (31,730 | ) |
| $ | (35,077 | ) |
| $ | (68,422 | ) |
Net income (loss) from discontinued operations attributable to shareholders |
|
| — |
|
|
| (80,890 | ) |
|
| — |
|
|
| (163,288 | ) |
Net income (loss) attributable to shareholders |
| $ | (13,797 | ) |
| $ | (112,620 | ) |
| $ | (35,077 | ) |
| $ | (231,710 | ) |
|
|
|
|
|
|
|
|
| ||||||||
Net income (loss) from continuing operations per share attributable to shareholders |
|
|
|
|
|
|
|
| ||||||||
Basic |
| $ | (0.31 | ) |
| $ | (0.65 | ) |
| $ | (0.78 | ) |
| $ | (1.64 | ) |
Diluted |
| $ | (0.31 | ) |
| $ | (0.65 | ) |
| $ | (0.78 | ) |
| $ | (1.64 | ) |
|
|
|
|
|
|
|
|
| ||||||||
Net income (loss) per share attributable to shareholders |
|
|
|
|
|
|
|
| ||||||||
Basic |
| $ | (0.31 | ) |
| $ | (2.33 | ) |
| $ | (0.78 | ) |
| $ | (5.05 | ) |
Diluted |
| $ | (0.31 | ) |
| $ | (2.33 | ) |
| $ | (0.78 | ) |
| $ | (5.05 | ) |
|
|
|
|
|
|
|
|
| ||||||||
Weighted-average number of common shares outstanding: |
|
|
|
|
|
|
|
| ||||||||
Basic |
|
| 45,419,403 |
|
|
| 48,106,069 |
|
|
| 45,371,409 |
|
|
| 47,862,071 |
|
Diluted |
|
| 45,419,403 |
|
|
| 48,106,069 |
|
|
| 45,371,409 |
|
|
| 47,862,071 |
|
OCTAVE SPECIALTY GROUP, INC. AND SUBSIDIARIES Consolidated Balance Sheets (Unaudited) | ||||||||
($ in thousands, except share data) |
|
September 30, |
|
June 30, | ||||
Assets: |
|
|
|
| ||||
Investments: |
|
|
|
| ||||
Fixed maturity securities, at fair value (amortized cost: $139,182 and $136,793) |
| $ | 132,134 |
|
| $ | 134,141 |
|
Short-term investments, at fair value (amortized cost: $93,408 and $82,513) |
|
| 93,408 |
|
|
| 82,513 |
|
Other investments (includes $7,913 and $7,498 at fair value) |
|
| 24,531 |
|
|
| 25,015 |
|
Total investments (net of allowance for credit losses of $0 and $0) |
|
| 250,073 |
|
|
| 241,669 |
|
Cash and cash equivalents (including $47,344 and $52,308 of restricted cash) |
|
| 79,148 |
|
|
| 79,096 |
|
Premium receivables (net of allowance for credit losses of $500 and $500) |
|
| 92,036 |
|
|
| 94,635 |
|
Commission and fees receivable |
|
| 94,613 |
|
|
| 100,537 |
|
Reinsurance recoverable on paid and unpaid losses (net of allowance for credit losses of $100 and $100) |
|
| 533,679 |
|
|
| 495,653 |
|
Deferred ceded premium |
|
| 154,911 |
|
|
| 148,236 |
|
Policy acquisition costs |
|
| 13,578 |
|
|
| 16,423 |
|
Intangible assets, less accumulated amortization |
|
| 435,835 |
|
|
| 447,448 |
|
Goodwill |
|
| 534,165 |
|
|
| 534,304 |
|
Other assets (net of allowance for credit losses of $350 and $350) |
|
| 113,467 |
|
|
| 122,856 |
|
Total assets |
| $ | 2,301,505 |
|
| $ | 2,280,857 |
|
Liabilities and Stockholders’ Equity: |
|
|
|
| ||||
Liabilities: |
|
|
|
| ||||
Unearned premiums |
| $ | 209,382 |
|
| $ | 202,890 |
|
Loss and loss adjustment expense reserves |
|
| 523,587 |
|
|
| 499,043 |
|
Ceded premiums payable |
|
| 100,177 |
|
|
| 93,346 |
|
Deferred program fees and reinsurance commissions |
|
| 7,024 |
|
|
| 6,989 |
|
Commission payable |
|
| 127,052 |
|
|
| 128,231 |
|
Deferred taxes |
|
| 56,097 |
|
|
| 58,855 |
|
Long-term debt |
|
| 154,767 |
|
|
| 155,459 |
|
Accrued interest payable |
|
| 30 |
|
|
| 27 |
|
Other liabilities |
|
| 124,564 |
|
|
| 120,643 |
|
Total liabilities |
|
| 1,302,680 |
|
|
| 1,265,483 |
|
Redeemable noncontrolling interest |
|
| 194,516 |
|
|
| 197,529 |
|
Stockholders’ equity: |
|
|
|
| ||||
Preferred stock, par value $0.01 per share; 20,000,000 shares authorized; issued and outstanding shares—none |
|
| — |
|
|
| — |
|
Common stock, par value $0.01 per share; 130,000,000 shares authorized; issued shares: 48,876,882 and 48,876,882 |
|
| 489 |
|
|
| 489 |
|
Additional paid-in capital |
|
| 383,894 |
|
|
| 379,561 |
|
Accumulated other comprehensive income (loss) |
|
| (1,140 | ) |
|
| 3,292 |
|
Retained earnings |
|
| 333,785 |
|
|
| 348,474 |
|
Treasury stock, shares at cost: 3,822,208 and 3,859,121 |
|
| (32,638 | ) |
|
| (33,063 | ) |
Total Octave Specialty Group, Inc. stockholders’ equity |
|
| 684,390 |
|
|
| 698,753 |
|
Nonredeemable noncontrolling interest |
|
| 119,919 |
|
|
| 119,092 |
|
Total stockholders’ equity |
|
| 804,309 |
|
|
| 817,845 |
|
Total liabilities, redeemable noncontrolling interest and stockholders’ equity |
| $ | 2,301,505 |
|
| $ | 2,280,857 |
|
Non-GAAP Financial Data
In addition to reporting the Company’s quarterly financial results in accordance with GAAP, the Company is reporting non-GAAP financial measures: EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin, Organic Revenue Growth Rate (Insurance Distribution segment only), Adjusted Net Income and Adjusted Net Income Margin. These amounts are derived from our consolidated financial information, but are not presented in our consolidated financial results because they are not calculated in accordance with GAAP.
We present non-GAAP supplemental financial information because we believe such information is of interest to the investment community, and that it provides greater transparency and enhanced visibility into the underlying drivers and performance of our businesses on a basis that may not be otherwise apparent on a GAAP basis. We view these non-GAAP financial measures as important indicators when assessing and evaluating our performance on a segmented and consolidated basis, and they are presented to improve the comparability of our results between periods by eliminating the impact of the items that may not be representative of our core operating performance. These non-GAAP financial measures are not substitutes for the Company’s GAAP reporting, should not be viewed in isolation, and may differ from similar reporting provided by other companies, which may define non-GAAP measures differently.
The following paragraphs define each non-GAAP financial measure. A tabular reconciliation of the non-GAAP financial measure to the most comparable GAAP financial measure is also presented below.
Non-GAAP Financial Measures
Organic Revenue (Insurance Distribution Only) — Organic Revenue is defined as Insurance Distribution segment total revenue for the relevant period excluding (i) the first twelve months of revenue (e.g. commissions and fees) generated from acquisitions, (ii) revenue from divestitures and (iii) other items such as contingent commissions, profit commissions and the impact of changes in foreign exchange rates.
Organic Revenue Growth is the change in Organic Revenue period-to-period, with prior period revenue adjusted to (i) include revenue (e.g. commissions and fees) that were excluded from Organic Revenue in the prior period which reached the twelve-month owned mark in the current period, (ii) exclude revenue related to divestitures and (iii) exclude other items such as contingent commissions, profit commissions and the impact of changes in foreign exchange rates.
Total Specialty P&C Insurance Production includes gross premiums written by Octave's Specialty P&C Insurance segment and premiums placed by the Insurance Distribution segment. Specialty P&C Insurance revenues are dependent on gross premiums written, as specialty program insurance companies earn premiums based on the portion of gross premiums written retained (i.e., net premiums written) and fees on gross premiums written that are ceded to reinsurers. Insurance Distribution revenues are dependent on premium volume, as Managing General Agents/Underwriters and brokers receive commissions based on the amount of premiums placed (i.e., gross premiums written on behalf of insurance carriers) with insurance carriers.
EBITDA — EBITDA is net income (loss) from continuing operations before interest expense, income taxes, depreciation and amortization of intangible assets.
EBITDA Margin — EBITDA divided by total revenues.
Adjusted EBITDA and Adjusted EBITDA Margin — We define Adjusted EBITDA as net income (loss) from continuing operations before interest expense, income taxes, depreciation, amortization of intangible assets, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, acquisition and integration-related expenses, severance, and other exceptional or non-recurring items, including those related to raising capital. We believe that Adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of income and expenses that may obfuscate business performance, and that the presentation of this measure enhances an investor's understanding of our financial performance.
Adjusted Net Income and Adjusted Net Income Margin — We define Adjusted Net Income as net income (loss) from continuing operations attributable to shareholders adjusted for amortization of intangible assets, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, acquisition and integration-related expenses, severance and non-recurring income and loss items that, in the opinion of management, significantly affect the period-over-period assessment of operating results, and the related tax effect of those adjustments. Per share amounts exclude any impact of revaluing noncontrolling interests as otherwise reported under GAAP earnings per share. We believe that Adjusted Net Income is an appropriate measure of operating performance because it eliminates the impact of income and expenses that may obfuscate business performance.
Results of Operations by Segment (Continued) | ||||||||||||||||||||
Three Months Ended September 30, 2026 |
|
Specialty
|
|
Insurance
|
|
Corporate &
|
| Eliminations |
| Consolidated | ||||||||||
($ in thousands) |
|
|
|
|
|
|
|
|
|
| ||||||||||
Gross premiums written |
| $ | 98,842 |
|
|
|
|
|
|
|
| $ | 98,842 |
| ||||||
Net premiums written |
|
| 25,633 |
|
|
|
|
|
|
|
|
| 25,633 |
| ||||||
Total revenues |
|
| 30,901 |
|
| $ | 58,364 |
|
| $ | (652 | ) |
| $ | (3,270 | ) |
|
| 85,343 |
|
Total expenses |
|
| 29,529 |
|
|
| 62,004 |
|
|
| 10,224 |
|
|
| (3,035 | ) |
|
| 98,722 |
|
Pretax income (loss) |
|
| 1,372 |
|
|
| (3,640 | ) |
|
| (10,876 | ) |
|
| (235 | ) |
|
| (13,379 | ) |
Provision (benefit) for income taxes |
|
| 101 |
|
|
| (525 | ) |
|
| (97 | ) |
|
| — |
|
|
| (521 | ) |
Net income (loss) |
| $ | 1,271 |
|
| $ | (3,115 | ) |
| $ | (10,779 | ) |
| $ | (235 | ) |
| $ | (12,858 | ) |
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Adjustments to EBITDA |
|
|
|
|
|
|
|
|
|
| ||||||||||
Add: Interest expense |
| $ | — |
|
| $ | 2,712 |
|
| $ | — |
|
|
| — |
|
| $ | 2,712 |
|
Add: Income tax expense |
|
| 101 |
|
|
| (525 | ) |
|
| (97 | ) |
|
| — |
|
|
| (521 | ) |
Add: Depreciation |
|
| — |
|
|
| 342 |
|
|
| 344 |
|
|
| — |
|
|
| 686 |
|
Add: Intangible amortization |
|
| — |
|
|
| 11,628 |
|
|
| — |
|
|
| — |
|
|
| 11,628 |
|
EBITDA |
| $ | 1,372 |
|
| $ | 11,042 |
|
| $ | (10,532 | ) |
| $ | (235 | ) |
| $ | 1,647 |
|
EBITDA attributable to shareholders |
| $ | 1,372 |
|
| $ | 7,446 |
|
| $ | (10,532 | ) |
| $ | (93 | ) |
| $ | (1,807 | ) |
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Adjustments to Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
| ||||||||||
Add: Acquisition and integration-related expenses |
| $ | — |
|
| $ | 171 |
|
| $ | (194 | ) |
| $ | — |
|
| $ | (23 | ) |
Add: Equity-based compensation expense |
|
| 342 |
|
|
| 1,042 |
|
|
| 2,472 |
|
|
| — |
|
|
| 3,856 |
|
Add: Severance and restructuring expense |
|
| 500 |
|
|
| — |
|
|
| 253 |
|
|
| — |
|
|
| 753 |
|
Add: Other non-operating (income) losses |
|
| — |
|
|
| — |
|
|
| 900 |
|
|
| — |
|
|
| 900 |
|
Adjusted EBITDA |
| $ | 2,214 |
|
| $ | 12,255 |
|
| $ | (7,101 | ) |
| $ | (235 | ) |
| $ | 7,133 |
|
Adjusted EBITDA attributable to shareholders |
| $ | 2,214 |
|
| $ | 8,313 |
|
| $ | (7,101 | ) |
| $ | (93 | ) |
| $ | 3,333 |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Net income (loss) |
| $ | 1,271 |
|
| $ | (3,115 | ) |
| $ | (10,779 | ) |
| $ | (235 | ) |
| $ | (12,858 | ) |
Adjustments: |
|
|
|
|
|
|
|
|
|
| ||||||||||
Add: Acquisition and integration-related expenses |
|
| — |
|
|
| 171 |
|
|
| (194 | ) |
|
| — |
|
|
| (23 | ) |
Add: Intangible amortization |
|
| — |
|
|
| 11,628 |
|
|
| — |
|
|
| — |
|
|
| 11,628 |
|
Add: Equity-based compensation expense |
|
| 342 |
|
|
| 1,042 |
|
|
| 2,472 |
|
|
| — |
|
|
| 3,856 |
|
Add: Severance and restructuring expense |
|
| 500 |
|
|
| — |
|
|
| 253 |
|
|
| — |
|
|
| 753 |
|
Add: Other non-operating (income) losses |
|
| — |
|
|
| — |
|
|
| 900 |
|
|
| — |
|
|
| 900 |
|
Adjusted net income (loss) before tax adjustments and NCI |
|
| 2,113 |
|
|
| 9,726 |
|
|
| (7,348 | ) |
|
| (235 | ) |
|
| 4,256 |
|
Income tax effects |
|
| (176 | ) |
|
| (2,329 | ) |
|
| 213 |
|
|
| — |
|
|
| (2,292 | ) |
Adjusted net income (loss) before NCI |
|
| 1,937 |
|
|
| 7,397 |
|
|
| (7,135 | ) |
|
| (235 | ) |
|
| 1,964 |
|
Net (income) loss attributable to noncontrolling interest |
|
| — |
|
|
| (3,371 | ) |
|
| — |
|
|
| 142 |
|
|
| (3,229 | ) |
Adjusted net income (loss) attributable to shareholders |
| $ | 1,937 |
|
| $ | 4,026 |
|
| $ | (7,135 | ) |
| $ | (93 | ) |
| $ | (1,265 | ) |
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Net income (loss) margin |
|
| 4.1 | % |
|
| (5.3 | )% |
|
| NM |
|
|
| NM |
|
|
| (15.1 | )% |
Adjusted EBITDA Margin |
|
| 7.2 | % |
|
| 21.0 | % |
|
| NM |
|
|
| NM |
|
|
| 8.4 | % |
Adjusted EBITDA Margin to shareholders |
|
| 7.2 | % |
|
| 14.2 | % |
|
| NM |
|
|
| NM |
|
|
| 3.9 | % |
Adjusted net income (loss) to shareholders margin |
|
| 6.3 | % |
|
| 6.9 | % |
|
| NM |
|
|
| NM |
|
|
| (1.5 | )% |
Contacts
Phil Stefano
Head of Investor Relations
(212) 208-3261
ir@octavegroup.com
Read full story here
Mentioned In This Article
Latest News
| Nov-10 | |
| Nov-09 | |
| Nov-09 | |
| Nov-02 | |
| Oct-23 | |
| Oct-19 | |
| Oct-08 | |
| Sep-29 | |
| Sep-08 | |
| Aug-06 | |
| Aug-06 | |
| Aug-03 | |
| Jul-17 | |
| May-06 | |
| May-06 |
